IL6 and Insulin resistance: Chronic activation of the hypothalamic-pituitary-adrenal and sympathetic-adrenal-medullary axes and associated mechanisms, in conjunction with resultant amplification of pro-inflammatory cytokines (through increased tumor necrosis factor-α and interleukin-6 production), all counteract insulin and may induce insulin resistance and β-cell dysfunction [30, 31].